1197P First-line lorlatinib versus crizotinib in ALK-positive non-small cell lung cancer: Asian subgroup analysis of CROWN
Invited conference paper presented and published in conference proceedings
Full Text
Digital Object Identifier (DOI) DOI for CUHK Users View Full-text in Publisher Website |
Altmetrics Information
.
Other information
All Author(s) ListZhou Q., Kim H.R., Soo R., Chang G-C., Chiu C-H., Hayashi H., Kim S-W., Teraoka S., Goto Y., Zhou J., Lee V.H.F., Han B., Ho J.C.M., Kim D-W., Lin C-C., Lu S., Polli A., Calella A.M., Mok T.S.K., Wu Y-L.
Name of ConferenceESMO Congress 2021
Start Date of Conference16/09/2021
End Date of Conference21/09/2021
Place of ConferenceParis
Country/Region of ConferenceFrance
Proceedings TitleAnnals of Oncology
Year2021
Month9
Volume Number32
Issue NumberSuppl 5
PagesS955 - S956
ISSN0923-7534
LanguagesEnglish-United Kingdom
